0000899243-21-046979.txt : 20211206
0000899243-21-046979.hdr.sgml : 20211206
20211206175327
ACCESSION NUMBER: 0000899243-21-046979
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211203
FILED AS OF DATE: 20211206
DATE AS OF CHANGE: 20211206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tucker John H
CENTRAL INDEX KEY: 0001303480
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38293
FILM NUMBER: 211474158
MAIL ADDRESS:
STREET 1: INDEVUS PHARMACEUTICALS, INC.
STREET 2: 99 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: scPharmaceuticals Inc.
CENTRAL INDEX KEY: 0001604950
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465184075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2400 DISTRICT AVENUE
STREET 2: SUITE 310
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 617-517-0730
MAIL ADDRESS:
STREET 1: 2400 DISTRICT AVENUE
STREET 2: SUITE 310
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-03
0
0001604950
scPharmaceuticals Inc.
SCPH
0001303480
Tucker John H
C/O SCPHARMACEUTICALS INC.
2400 DISTRICT AVENUE, SUITE 310
BURLINGTON
MA
01803
1
1
0
0
President and CEO
Common Stock
2021-12-03
4
P
0
10000
3.9553
A
46962
D
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.78 to $4.00, inclusive. The reporting person undertakes to provide to scPharmaceuticals Inc., any security holder of scPharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4
/s/ John H. Tucker
2021-12-06